UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
Aquila Biopharmaceuticals, Inc.
(Name of Issuer)
Common Stock, $.01 par value
(Title of Class of Securities)
03839F107
(CUSIP Number)
May 4, 1998
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:
[ ] Rule 13d-1(b)
[X] Rule 13d-1(c)
[ ] Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of 13 pages
<PAGE>
CUSIP NO. 03839F107
- -------------------------------------------------------------------------------
1. Name of Reporting Person
I.R.S. Identification No. of above person (entities only)
Marcus Schloss & Co., Inc.
TP # 13-5676531
- -------------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group (See Instructions)
(a) [ ]
(b) [ ]
- -------------------------------------------------------------------------------
3. SEC Use Only
- -------------------------------------------------------------------------------
4. Citizenship or Place of Organization
New York
- -------------------------------------------------------------------------------
5. Sole Voting Power
Number of 506,572*
Shares -------------------------------------------------------------
Beneficially 6. Shared Voting Power
Owned by None
Each -------------------------------------------------------------
Reporting 7. Sole Dispositive Power
Person 506,572*
With: -------------------------------------------------------------
8. Shared Dispositive Power
None
- -------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person
506,572*
- -------------------------------------------------------------------------------
10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares
(See Instructions)
[ ]
- -------------------------------------------------------------------------------
11. Percent of Class Represented by Amount in Row (9)
7.3%
- -------------------------------------------------------------------------------
12. Type of Reporting Person (See Instructions)
BD
- -------------------------------------------------------------------------------
Page 2 of 13 pages
<PAGE>
CUSIP NO. 03839F107
- -------------------------------------------------------------------------------
1. Name of Reporting Person
I.R.S. Identification No. of above person (entities only)
Douglas Schloss
- -------------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group (See Instructions)
(a) [ ]
(b) [ ]
- -------------------------------------------------------------------------------
3. SEC Use Only
- -------------------------------------------------------------------------------
4. Citizenship or Place of Organization
U.S.A.
- -------------------------------------------------------------------------------
5. Sole Voting Power
Number of 576,672*
Shares -------------------------------------------------------------
Beneficially 6. Shared Voting Power
Owned by None
Each -------------------------------------------------------------
Reporting 7. Sole Dispositive Power
Person 576,672*
With: -------------------------------------------------------------
8. Shared Dispositive Power
None
- -------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person
576,672*
- -------------------------------------------------------------------------------
10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares
(See Instructions)
[ ]
- -------------------------------------------------------------------------------
11. Percent of Class Represented by Amount in Row (9)
8.3%
- -------------------------------------------------------------------------------
12. Type of Reporting Person (See Instructions)
IN
- -------------------------------------------------------------------------------
Page 3 of 13 pages
<PAGE>
CUSIP NO. 03839F107
- -------------------------------------------------------------------------------
1. Name of Reporting Person
I.R.S. Identification No. of above person (entities only)
Richard Perry Schloss
- -------------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group (See Instructions)
(a) [ ]
(b) [ ]
- -------------------------------------------------------------------------------
3. SEC Use Only
- -------------------------------------------------------------------------------
4. Citizenship or Place of Organization
U.S.A.
- -------------------------------------------------------------------------------
5. Sole Voting Power
Number of 576,672*
Shares -------------------------------------------------------------
Beneficially 6. Shared Voting Power
Owned by None
Each -------------------------------------------------------------
Reporting 7. Sole Dispositive Power
Person 576,672*
With: -------------------------------------------------------------
8. Shared Dispositive Power
None
- -------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person
576,672*
- -------------------------------------------------------------------------------
10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares
(See Instructions)
[ ]
- -------------------------------------------------------------------------------
11. Percent of Class Represented by Amount in Row (9)
8.3%
- -------------------------------------------------------------------------------
12. Type of Reporting Person (See Instructions)
IN
- -------------------------------------------------------------------------------
Page 4 of 13 pages
<PAGE>
* Each of Douglas Schloss and Richard P. Schloss may be
deemed to control Marcus Schloss & Co., Inc. ("Marcus
Schloss") and thus each of Douglas Schloss, Richard P.
Schloss and Marcus Schloss may be considered to have
beneficial ownership of, and voting and dispositive
power over, the 506,572 shares of Common Stock, par
value $.01 per share ("Common Stock"), of Aquila
Biopharmaceuticals, Inc. (the "Company") owned of
record by Marcus Schloss. In addition, each of Douglas
Schloss and Richard P. Schloss may be deemed to control
two private investment funds (the "Funds") which, in
the aggregate, beneficially own 70,100 shares of Common
Stock. Accordingly, each of Douglas Schloss and
Richard P. Schloss may be considered to have beneficial
ownership of, and voting and dispositive power over,
the aggregate of 576,672 shares of Common Stock
beneficially owned by Marcus Schloss and the Funds.
All information regarding Common Stock ownership in this
Amendment No. 1 to Schedule 13G is provided as of May 4, 1998.
Page 5 of 13 pages
<PAGE>
The Statement on Schedule 13G, dated February 11, 1998, of Marcus
Schloss & Co., Inc., Douglas Schloss and Richard P. Schloss relating to shares
of Common Stock, $.01 par value, of Aquila Biopharmaceuticals, Inc., a Delaware
corporation, is hereby amended to insert the following information in response
to the items indicated.
Item 1(a). Name of Issuer
Aquila Biopharmaceuticals, Inc.
Item 1(b). Address of Issuer's Principal Executive Offices
365 Plantation Street
Worcester, Massachusetts 01605
Item 2(a). Names of Persons Filing
Marcus Schloss & Co., Inc. ("Marcus Schloss"), Douglas Schloss and
Richard P. Schloss. Each of Douglas Schloss and Richard P. Schloss may be deemed
to control Marcus Schloss.
Item 2(b). Address of Principal Business Office
One Whitehall Street
New York, New York 10004
Item 2(c). Citizenship
Marcus Schloss is a New York corporation. Douglas Schloss and Richard
P. Schloss are United States citizens.
Item 2(d). Title of Class of Securities
Common Stock
Item 2(e). CUSIP Number
03839F107
Item 3. IF THIS STATEMENT IS FILED PURSUANT TO SS.SS.
240.13D-1(B) OR 240.13(D)-2(B) OR (C), CHECK WHETHER THE
PERSON FILING IS A:
(a) [ ] Broker or dealer registered under Section 15 of
the Act (15 U.S.C. 780);
(b) [ ] Bank as defined in Section 3(a)(6) of the Act
(15 U.S.C. 78c);
Page 6 of 13 pages
<PAGE>
(c) [ ] Insurance company as defined in
Section 3(a)(19)of the Act (15
U.S.C. 78c);
(d) [ ] Investment company registered under
Section 8 of the Investment Company
Act (15 U.S.C. 80a-8);
(e) [ ] An investment adviser in accordance
with ss. 240.13d-1(b)(l)(ii)(E);
(f) [ ] An employee benefit plan or endowment
fund in accordance with ss. 240.13d-
1(b)(1)(ii)(F);
(g) [ ] A parent holding company or control
person in accordance with ss. 240.13d-
1(b)(ii)(G);
(h) [ ] A savings association as defined in
Section 3(b) of the Federal Deposit
Insurance Act (12 U.S.C. 1813);
(i) [ ] A church plan that is excluded from
the definition of an investment company
under Section 3(c)(14) of the Investment
Company Act of 1940 (15 U.S.C. 80a-3);
(j) [ ] Group, in accordance with ss. 240.13d-
1(b)(1)(ii)(J).
Item 4. Ownership
I. Marcus Schloss & Co., Inc.
(a) Amount Beneficially Owned: 506,572 shares
(b) Percent of Class: 7.3%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 506,572
(ii) shared power to vote or to direct the vote: None
(iii) sole power to dispose or to direct the disposition
of: 507,572
Page 7 of 13 pages
<PAGE>
(iv) shared power to dispose or to direct the disposition
of: None
II. Douglas Schloss
(a) Amount Beneficially Owned: 576,672 shares
(b) Percent of Class: 8.3%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 576,672
(ii) shared power to vote or to direct the vote: None
(iii) sole power to dispose or to direct the disposition
of: 576,672
(iv) shared power to dispose or to direct the disposition
of: None
III. Richard Schloss
(a) Amount Beneficially Owned: 576,672 shares
(b) Percent of Class: 8.3%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 576,672
(ii) shared power to vote or to direct the vote: None
(iii) sole power to dispose or to direct the disposition
of: 576,672
(iv) shared power to dispose or to direct the disposition
of: None
Marcus Schloss has record ownership of 506,572 shares of Common Stock
and has the sole power to vote and the sole power to dispose of all such shares.
Each of Douglas Schloss and Richard P. Schloss may be deemed to
Page 8 of 13 pages
<PAGE>
control each of (i) Marcus Schloss, and (ii) two private investment funds (the
"Funds") which, in the aggregate, beneficially own 70,100 shares of Common
Stock. Accordingly, each of Douglas Schloss and Richard P. Schloss may be
considered to have beneficial ownership of the aggregate of 576,672 shares of
Common Stock beneficially owned by Marcus Schloss and the Funds.
Marcus Schloss, Douglas Schloss and Richard P. Schloss originally filed
a joint Statement on Schedule 13G with the Securities and Exchange Commission
(the "Commission") in respect of the Common Stock on February 11, 1998. At that
time, the Funds in the aggregate beneficially owned less than 1.0% of the
outstanding Common Stock. The Funds are not persons of a type specified in
Commission Rule 13d-1(b)(ii)(A) through (I). As of May 4, 1998 (trade date), the
Funds acquired shares of Common Stock that caused their aggregate beneficial
ownership to exceed 1.0% of the class. By reason of such acquisition, Douglas
Schloss and Richard P. Schloss became ineligible to file Schedule 13G as
"control persons" under Rule 13d-1(b)(ii)(G). Marcus Schloss, Douglas Schloss
and Richard P. Schloss accordingly are filing this Amendment No. 1 to Schedule
13G pursuant to Rule 13d-1(g).
Alison Schloss, the spouse of Douglas Schloss, is the trustee of two
trusts which, in the aggregate, beneficially own 3,478 shares of Common Stock.
The beneficiaries of such trusts are the children of Alison Schloss and Douglas
Schloss. Douglas Schloss disclaims beneficial ownership of all such shares of
Common Stock owned by such trusts.
Item 5. Ownership of Five Percent or Less of a Class
Not applicable.
Item 6. Ownership of More Than Five Percent on Behalf of Another Person
As described in the footnote to the cover pages and in response to Item
4 above, each of Douglas Schloss and Richard P. Schloss may be deemed to control
the Funds which, in the aggregate, beneficially own 70,100 shares of Common
Stock. Each Fund is entitled to the full economic benefits of all shares of
Common Stock owned by it.
Item 7. Identification and Classification of the Subsidiary Which Acquired
the Security Being Reported on by the Parent Holding Company
Not applicable.
Page 9 of 13 pages
<PAGE>
Item 8. Identification and Classification of Members of the Group
Not applicable.
Item 9. Notice of Dissolution of Group
Not applicable.
Item 10. Certification
By signing below each of the undersigned certifies that, to the best of
its or his knowledge and belief, the securities referred to above were not
acquired and are not held for the purpose of or with the effect of changing or
influencing the control of the issuer of the securities and were not acquired
and are not held in connection with or as a participant in any transaction
having that purpose or effect.
DISCLAIMER
Each of Douglas Schloss and Richard P. Schloss hereby declares that the
filing of this Amendment No. 1 to Schedule 13G shall not be construed as an
admission that he is, for the purposes of Section 13(d) or 13(g) of the
Securities Exchange Act of 1934, the beneficial owner of any securities covered
herein.
Page 10 of 13 pages
<PAGE>
SIGNATURES
After reasonable inquiry and to the best knowledge and belief of each,
the undersigned certify that the information set forth in this statement is
true, complete and correct.
Date: May 8, 1998
MARCUS SCHLOSS & CO., INC.
By: /s/ Douglas Schloss
----------------------------------
Douglas Schloss
Chairman
DOUGLAS SCHLOSS
/s/ Douglas Schloss
----------------------------------
Douglas Schloss
RICHARD P. SCHLOSS
/s/ Richard P. Schloss
----------------------------------
Richard P. Schloss
Page 11 of 13 pages
<PAGE>
EXHIBIT INDEX
Exhibit No. Description Page
- ----------- ----------- ----
99.1 Joint Filing Agreement, dated May 8, 1998 13
Page 12 of 13 pages
Exhibit A
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act
of 1934, as amended, the undersigned hereby agree to the joint filing on behalf
of each of them of a statement on Schedule 13G (including amendments thereto)
with respect to the Common Stock of Aquila Biopharmaceuticals, Inc., and that
this Agreement be included as an Exhibit to such joint filing. This Agreement
may be executed in counterparts all of which taken together shall constitute one
and the same instrument.
IN WITNESS WHEREOF, the undersigned hereby execute this Agreement
this 8th day of May, 1998.
/s/ Douglas Schloss
-----------------------------
Douglas Schloss
/s/ Richard P. Schloss
-----------------------------
Richard P. Schloss
MARCUS SCHLOSS & CO., INC.
By: /s/ Douglas Schloss
-------------------------
Douglas Schloss
Chairman
